Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Other Operating Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Operating Expenses for 16 consecutive years, with $11.7 million as the latest value for Q3 2025.

  • Quarterly Other Operating Expenses fell 1.21% to $11.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $46.2 million through Sep 2025, down 7.68% year-over-year, with the annual reading at $49.2 million for FY2024, 4821.4% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $11.7 million at Xtant Medical Holdings, up from $11.6 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $13.2 million in Q2 2024, with the low at -$20.0 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is $4.6 million, with a median of $5.3 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses crashed 477.02% in 2022, then soared 659.62% in 2024.
  • Over 5 years, Other Operating Expenses stood at $5.3 million in 2021, then plummeted by 477.02% to -$20.0 million in 2022, then soared by 162.75% to $12.6 million in 2023, then fell by 7.05% to $11.7 million in 2024, then grew by 0.53% to $11.7 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $11.7 million, $11.6 million, and $11.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.